Piper Jaffray analyst, Gene Munster, cut his estimates and price target for Marchex (NASDAQ: MCHX) but maintained the Overweight rating ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE